1. Cell replacement therapy for Parkinson''s disease: how close are we to the clinic?. (September 2011) Authors: Ganz, Javier; Lev, Nirit; Melamed, Eldad; Offen, Daniel Journal: Expert review of neurotherapeutics Issue: Volume 11:Number 9(2011) Page Start: 1325 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Harnessing neurogenesis for the possible treatment of Parkinson's disease. Issue 12 (9th May 2014) Authors: Lamm, Omri; Ganz, Javier; Melamed, Eldad; Offen, Daniel Journal: Journal of comparative neurology Issue: Volume 522:Issue 12(2014:Aug. 15) Page Start: 2817 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Rare combination of myasthenia and motor neuronopathy, responsive to Msc‐Ntf stem cell therapy. Issue 3 (20th January 2014) Authors: Petrou, Panayiota; Argov, Avizohar; Lennon, Vanda A.; Gotkine, Marc; Kassis, Ibrahim; Vaknin‐Dembinsky, Adi; Ben‐Hur, Tamir; Offen, Daniel; Abramsky, Oded; Melamed, Eldad; Karussis, Dimitrios Journal: Muscle & nerve Issue: Volume 49:Issue 3(2014:Mar.) Page Start: 455 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. The G2019S LRRK2 mutation: Another morbid burden for Ashkenazi Jews may provide new insights on sporadic Parkinson's disease. Issue 14 (4th December 2013) Authors: Melamed, Eldad Journal: Movement disorders Issue: Volume 28:Issue 14(2013) Page Start: 1912 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Trial designs used to study neuroprotective therapy in Parkinson's disease. Issue 1 (23rd August 2012) Authors: Lang, Anthony E.; Melamed, Eldad; Poewe, Werner; Rascol, Olivier Journal: Movement disorders Issue: Volume 28:Issue 1(2013) Page Start: 86 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗